当前位置:首页 - 行情中心 - 开立医疗(300633) - 财务分析

开立医疗

(300633)

  

流通市值:143.01亿  总市值:143.01亿
流通股本:4.33亿   总股本:4.33亿

开立医疗(300633)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润0.47亿元,每股收益0.11元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益311551.37万元,未分配利润141697.71万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产401776.99万元,负债90225.62万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入964,264,625430,012,001.932,013,856,558.551,398,196,592.81
营业总成本955,582,429.16444,124,458.111,893,816,500.891,351,044,835.32
其他经营收益
营业利润34,472,560.487,571,345.71121,555,950.82115,702,869.43
利润总额34,808,519.657,136,177.66120,189,228.74115,591,958.78
净利润47,030,261.688,074,620.52142,397,376.09108,985,799.47
每股收益
其他综合收益-3,848,775.414,674,919.5-7,777,830.842,331,694.88
综合收益总额43,181,486.2712,749,540.02134,619,545.25111,317,494.35
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计2,604,158,805.182,645,522,089.152,974,995,087.772,890,010,108.38
非流动资产:
非流动资产合计1,413,611,125.951,350,318,398.541,338,002,067.461,266,127,937.22
资产总计4,017,769,931.133,995,840,487.694,312,997,155.234,156,138,045.6
流动负债:
流动负债合计788,048,411.4750,031,277.731,083,288,724.37935,180,788.14
非流动负债:
非流动负债合计114,207,812.55121,291,199.53121,485,951.45100,829,314.67
负债合计902,256,223.95871,322,477.261,204,774,675.821,036,010,102.81
所有者权益(或股东权益):
归属于母公司股东权益合计3,115,513,707.183,124,518,010.433,108,222,479.413,120,127,942.79
股东权益合计3,115,513,707.183,124,518,010.433,108,222,479.413,120,127,942.79
负债和股东权益合计4,017,769,931.133,995,840,487.694,312,997,155.234,156,138,045.6
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计1,085,584,203.39442,619,029.862,546,012,605.751,694,856,768.64
经营活动现金流出小计1,335,883,536.41727,483,571.772,239,354,350.371,662,950,692.65
经营活动产生的现金流量净额-250,299,333.02-284,864,541.91306,658,255.3831,906,075.99
投资活动产生的现金流量:
投资活动现金流入小计655,974,893.76499,535,533.271,015,994,445.02781,784,607.33
投资活动现金流出小计286,844,363.48179,389,108.541,607,132,005.731,209,690,045.25
投资活动产生的现金流量净额369,130,530.28320,146,424.73-591,137,560.71-427,905,437.92
筹资活动产生的现金流量:
筹资活动现金流入小计142,916,002.4221,167,720.37443,470,753.5366,804,161.81
筹资活动现金流出小计318,536,693.98175,584,712.35361,233,644.87206,689,967.77
筹资活动产生的现金流量净额-175,620,691.56-154,416,991.9882,237,108.63160,114,194.04
汇率变动对现金及现金等价物的影响727,637.481,084,263.85-426,060.23-763,999.99
现金及现金等价物净增加额-56,061,856.82-118,050,845.31-202,668,256.93-236,649,167.88
期末现金及现金等价物余额1,466,499,915.951,404,510,927.461,522,561,772.771,488,580,861.82
补充资料:
现金及现金等价物的净增加额-56,061,856.82--202,668,256.93-
最新报告期:2025-10-10
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中信建投王在存,贺菊颖0.490.781.072025-10-10
华创证券郑辰,李婵娟0.700.941.252025-09-30
浙商证券司清蕊0.470.700.962025-09-15
海通国际LuMeng,WenxinYu,KehanMeng0.590.861.102025-09-05
国盛证券杨芳,张金洋0.610.831.162025-09-04
TOP↑